Search research articles
Contact Us
Filters
Showing results (411-420 of 459) with videos related to
Page
of 46
Sort By:
Neuro-Oncology
|
March 8, 2011
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03
Fabio M Iwamoto, Kathleen R Lamborn, John G Kuhn, et al.
Research Square
|
November 24, 2025
Post-Chemoradiation Lymphopenia and Baseline Eosinophil Counts as Prognostic Markers in Glioblastoma
Eric Giannaris, Geoffrey Sedor, Catherine S Spina, et al.
BMC Cancer
|
May 28, 2026
Eosinophil counts as a prognostic marker in glioblastoma: a retrospective cohort study
Eric Giannaris, Geoffrey Sedor, Catherine S Spina, et al.
Neuro-Oncology
|
March 5, 2010
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)
Fabio M Iwamoto, Kathleen R Lamborn, H Ian Robins, et al.
Journal of Neuro-Oncology
|
June 29, 2011
Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas
Fabio M Iwamoto, Andreas F Hottinger, Sasan Karimi, et al.
Neuro-Oncology
|
August 12, 2011
Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas
Fabio M Iwamoto, Andreas F Hottinger, Sasan Karimi, et al.
Annals of Neurology
|
March 11, 2011
YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma
Andreas F Hottinger, Fabio M Iwamoto, Sasan Karimi, et al.
Neuro-Oncology
|
June 14, 2024
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma
Andrew E Sloan, Kathryn Winter, Mark R Gilbert, et al.
Scientific Reports
|
January 9, 2021
Consequence of aging at Au/HTM/perovskite interface in triple cation 3D and 2D/3D hybrid perovskite solar cells
Zubair Ahmad, Arti Mishra, Sumayya M Abdulrahim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 21, 2010
Scale to predict survival after surgery for recurrent glioblastoma multiforme
John K Park, Tiffany Hodges, Leopold Arko, et al.
Page
of 46
Search research articles
Search
Showing results (411-420 of 459) with videos related to
Sort By:
Page
of 46
Neuro-Oncology
|
March 8, 2011
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03
Fabio M Iwamoto, Kathleen R Lamborn, John G Kuhn, et al.
Research Square
|
November 24, 2025
Post-Chemoradiation Lymphopenia and Baseline Eosinophil Counts as Prognostic Markers in Glioblastoma
Eric Giannaris, Geoffrey Sedor, Catherine S Spina, et al.
BMC Cancer
|
May 28, 2026
Eosinophil counts as a prognostic marker in glioblastoma: a retrospective cohort study
Eric Giannaris, Geoffrey Sedor, Catherine S Spina, et al.
Neuro-Oncology
|
March 5, 2010
Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)
Fabio M Iwamoto, Kathleen R Lamborn, H Ian Robins, et al.
Journal of Neuro-Oncology
|
June 29, 2011
Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas
Fabio M Iwamoto, Andreas F Hottinger, Sasan Karimi, et al.
Neuro-Oncology
|
August 12, 2011
Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas
Fabio M Iwamoto, Andreas F Hottinger, Sasan Karimi, et al.
Annals of Neurology
|
March 11, 2011
YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma
Andreas F Hottinger, Fabio M Iwamoto, Sasan Karimi, et al.
Neuro-Oncology
|
June 14, 2024
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma
Andrew E Sloan, Kathryn Winter, Mark R Gilbert, et al.
Scientific Reports
|
January 9, 2021
Consequence of aging at Au/HTM/perovskite interface in triple cation 3D and 2D/3D hybrid perovskite solar cells
Zubair Ahmad, Arti Mishra, Sumayya M Abdulrahim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 21, 2010
Scale to predict survival after surgery for recurrent glioblastoma multiforme
John K Park, Tiffany Hodges, Leopold Arko, et al.
Page
of 46